Anne Spinewine
@aspinewine.bsky.social
Clinical pharmacist, researcher and teacher. Optimising medication use in clinical practice; reducing medication overuse through deprescribing; leveraging implementation science to make change happen.
🚀 New study in JAMA Network Open explores #barriers to #deprescribing #benzodiazepines in hospital physicians and GPs across 6 European countries—the first multinational, theory-based investigation on this topic!
📖 Read more: lnkd.in/e7__ead7
#Deprescribing #Geriatrics #MedicationSafety
📖 Read more: lnkd.in/e7__ead7
#Deprescribing #Geriatrics #MedicationSafety
March 20, 2025 at 8:12 AM
🚀 New study in JAMA Network Open explores #barriers to #deprescribing #benzodiazepines in hospital physicians and GPs across 6 European countries—the first multinational, theory-based investigation on this topic!
📖 Read more: lnkd.in/e7__ead7
#Deprescribing #Geriatrics #MedicationSafety
📖 Read more: lnkd.in/e7__ead7
#Deprescribing #Geriatrics #MedicationSafety
doi.org/10.1111/phn.... In this systematic review, we found that Health Behavior Theories have been little used to explain and predict #deprescribing outcomes. Combining the main #HBT constructs reported in the literature offers a better explanation of the (intention to) engage in deprescribing.
January 8, 2025 at 10:45 AM
doi.org/10.1111/phn.... In this systematic review, we found that Health Behavior Theories have been little used to explain and predict #deprescribing outcomes. Combining the main #HBT constructs reported in the literature offers a better explanation of the (intention to) engage in deprescribing.